Nar H - Search Results

1

Synthesis of cyclic dipeptide templates, their incorporation into peptides and studies on their conformational and biological properties.

Asche G, Kunz H, Nar H, Köppen H, Briem H, Pook KH, Schiller PW, Chung NN, Lemieux C, Esser F. Asche G, et al. Among authors: nar h. J Pept Res. 1998 May;51(5):323-36. doi: 10.1111/j.1399-3011.1998.tb01223.x. J Pept Res. 1998. PMID: 9606012

2

Repaglinide and related hypoglycemic benzoic acid derivatives.

Grell W, Hurnaus R, Griss G, Sauter R, Rupprecht E, Mark M, Luger P, Nar H, Wittneben H, Müller P. Grell W, et al. Among authors: nar h. J Med Chem. 1998 Dec 17;41(26):5219-46. doi: 10.1021/jm9810349. J Med Chem. 1998. PMID: 9857091

3

Structural basis for inhibition promiscuity of dual specific thrombin and factor Xa blood coagulation inhibitors.

Nar H, Bauer M, Schmid A, Stassen JM, Wienen W, Priepke HW, Kauffmann IK, Ries UJ, Hauel NH. Nar H, et al. Structure. 2001 Jan 10;9(1):29-37. doi: 10.1016/s0969-2126(00)00551-7. Structure. 2001. PMID: 11342132 Free article.

4

Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation.

Pautsch A, Zoephel A, Ahorn H, Spevak W, Hauptmann R, Nar H. Pautsch A, et al. Among authors: nar h. Structure. 2001 Oct;9(10):955-65. doi: 10.1016/s0969-2126(01)00655-4. Structure. 2001. PMID: 11591350 Free article.

5

Structure-based design of novel potent nonpeptide thrombin inhibitors.

Hauel NH, Nar H, Priepke H, Ries U, Stassen JM, Wienen W. Hauel NH, et al. Among authors: nar h. J Med Chem. 2002 Apr 25;45(9):1757-66. doi: 10.1021/jm0109513. J Med Chem. 2002. PMID: 11960487

6

Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke.

Grauert M, Bechtel WD, Weiser T, Stransky W, Nar H, Carter AJ. Grauert M, et al. Among authors: nar h. J Med Chem. 2002 Aug 15;45(17):3755-64. doi: 10.1021/jm020875j. J Med Chem. 2002. PMID: 12166948

7

Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection.

Tsantrizos YS, Bolger G, Bonneau P, Cameron DR, Goudreau N, Kukolj G, LaPlante SR, Llinàs-Brunet M, Nar H, Lamarre D. Tsantrizos YS, et al. Among authors: nar h. Angew Chem Int Ed Engl. 2003 Mar 28;42(12):1356-60. doi: 10.1002/anie.200390347. Angew Chem Int Ed Engl. 2003. PMID: 12671967 No abstract available.

8

Heterocyclic thrombin inhibitors. Part 1: design and synthesis of amidino-phenoxy quinoline derivatives.

Ries UJ, Priepke HW, Hauel NH, Haaksma EE, Stassen JM, Wienen W, Nar H. Ries UJ, et al. Among authors: nar h. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2291-5. doi: 10.1016/s0960-894x(03)00442-6. Bioorg Med Chem Lett. 2003. PMID: 12824020

9

Heterocyclic thrombin inhibitors. Part 2: quinoxalinone derivatives as novel, potent antithrombotic agents.

Ries UJ, Priepke HW, Hauel NH, Handschuh S, Mihm G, Stassen JM, Wienen W, Nar H. Ries UJ, et al. Among authors: nar h. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2297-302. doi: 10.1016/s0960-894x(03)00443-8. Bioorg Med Chem Lett. 2003. PMID: 12824021

10

Crystal structure of the human liver X receptor beta ligand-binding domain in complex with a synthetic agonist.

Hoerer S, Schmid A, Heckel A, Budzinski RM, Nar H. Hoerer S, et al. Among authors: nar h. J Mol Biol. 2003 Dec 12;334(5):853-61. doi: 10.1016/j.jmb.2003.10.033. J Mol Biol. 2003. PMID: 14643652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters